News

I-PASS Appoints Healthcare Leader and Patient Safety Expert Patricia McGaffigan to Its Board of Directors

Accomplished industry executive adds extensive leadership experience improving the safety and quality of patient careBOSTON--(BUSINESS WIRE)--I-PASS, the gold standard for…

2 years ago

Pathways Health Partners Ushers in a New Era of Healthcare Leadership with Dr. Lubna Rashid as CMO

LEESBURG, FL / ACCESSWIRE / April 9, 2024 / In a significant stride towards pioneering excellence in healthcare, Pathways Health…

2 years ago

Local Atlanta Lasik Eye Surgeon Successfully Performs Over 150,000 Laser Vision Correction Procedures, Earning His Place Among the Nation’s Most Experienced Lasik Surgeons

ATLANTA, GA / ACCESSWIRE / April 9, 2024 / Atlanta-based ophthalmologist and LASIK eye surgeon Dr. Eugene Smith, Medical Director…

2 years ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

2 years ago

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

2 years ago

Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer

PARIS, April 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in the Netherlands…

2 years ago

Virbac : Declaration of the number of shares and voting rights 03/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares…

2 years ago

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox’s…

2 years ago

STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan

Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively…

2 years ago

Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma

BASKING RIDGE, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

2 years ago